Diseases, Conditions, Syndromes

Liver damage in hepatitis C patients significantly underestimated

The number of hepatitis C patients suffering from advanced liver damage may be grossly underestimated and underdiagnosed, according to a study led by researchers at Henry Ford Health System and the U.S. Centers for Disease ...

Medical research

Researchers implicate well-known protein in fibrosis

An international multi-disciplinary research team led by Northwestern Medicine scientists has uncovered a new role for the protein toll-like receptor 4 (TLR4) in the development of tissue fibrosis, or scarring.

Health

CDC: Add $2 per drink for US excessive drinking

(AP) -- The toll of excessive drinking works out to about $2 per drink, in terms of medical expenses and other costs to society, according to a new federal research.

Medical research

Rebooting cell programming can reverse liver failure

It might be possible to heal cirrhotic liver disease by rebooting the genes that control liver cell function, according to researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of ...

Oncology & Cancer

Studies identify risk factors in rising trend of liver cancer

Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings ...

Diseases, Conditions, Syndromes

Combination of oral drugs suppresses common type of hepatitis C

A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.

page 7 from 27